Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
European Journal of Cancer & Clinical Oncology|February 1, 1984
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomitingF Cognetti, P Pinnarò, P Carlini, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combinationF Cognetti, P Pinnaro, P Carlini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II studyM Nardi, F Cognetti, C F Pollera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2011
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialF Cognetti, E M Ruggeri, A Felici, et al.International Journal of Clinical Pharmacology Research|January 1, 1996
Gemcitabine: safety profile unaffected by starting doseC Martin, C F PolleraCancer|September 1, 1989
Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic modelC F Pollera, D GiannarelliAmerican Journal of Clinical Oncology|June 1, 1997
Paclitaxel as salvage therapy in advanced pretreated ovarian cancer: a phase II studyM Nardi, A Aloe, S De Marco, et al.Cancer Chemotherapy and Pharmacology|June 15, 2000
Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II studyM Nardi, S De Marco, A Fabi, et al.Investigational New Drugs|January 1, 1994
Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I studyC F Pollera, A Ceribelli, M Crecco, et al.Pageof 12